Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
Research at a glance
Focus
Biomarkers in Interstitial Lung Disease, Clinical Trials in Interstitial Lung Disease, Role of Th1 & Th2 pathways and biomarkers in Sarcoidosis
Active clinical trials
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
My publications
Filter publications
10 publications
2015
A 41-year-old woman with shortness of breath and history of rash and recurrent laryngeal edema.
Chest
PubMed • Publisher's site2012
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis.
The European respiratory journal
PubMed • Publisher's site2010
Hantavirus pulmonary syndrome.
Infectious disease clinics of North America
PubMed • Publisher's site2010
Targeted delivery of amikacin into granuloma.
American journal of respiratory and critical care medicine
PubMed • Publisher's site2008
Acute respiratory distress syndrome: time to entertain a change but not to make one.
Critical care medicine
PubMed • Publisher's site